Literature DB >> 26003656

Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Ermioni Prapa1, Anna Vasilaki, Konstantinos Dafopoulos, Eleni Katsiani, Panagiotis Georgoulias, Christina I Messini, George Anifandis, Ioannis E Messinis.   

Abstract

PURPOSE: To determine if there is any effect of AMH and BMP-15 on estradiol and progesterone production from primary-cultured human luteinizing granulosa cells, to delineate what is the effect of FSH on their actions and which are the possible mechanisms involved.
METHODS: Luteinizing granulosa cells (GCs), obtained from follicular fluid of 30 women undergoing in vitro fertilization, were cultured, after a short 24-h preincubation period, in serum-free medium for 24 or/and 48 h in the presence/absence of various concentrations of AMH, BMP-15 and FSH alone or in combinations. Estradiol and progesterone production, SMAD5 phosphorylation and StAR expression were studied in parallel. Steroids were measured in culture-supernatant using enzyme-immunoassays, while Smad5-signaling pathway activation and StAR protein expression were assessed immunocytochemically. RESULT(S): We found that the treatment of AMH in GCs for 24/48 h attenuated FSH-induced estradiol production (p < 0.001), had no effect on basal estradiol levels, decreased basal progesterone production (p < 0.001) and FSH-induced StAR expression (p < 0.001). On the other hand, BMP-15 decreased basal estradiol levels (p < 0.001) and attenuated FSH-induced estradiol production (p < 0.001). Furthermore, BMP-15 reduced progesterone basal secretion (p < 0.001), an effect that was partially reversed by FSH (p < 0.01), probably via increasing StAR expression (p < 0.001). FSH-induced StAR expression was also attenuated by BMP-15 (p < 0.001). FSH, AMH and BMP-15 activated Smad-signaling pathway, as confirmed by the increase of phospo-Smad5 protein levels (p < 0.001 compared to control). CONCLUSION(S): AMH and BMP-15 by interacting with FSH affect the production of estradiol and progesterone from cultured luteinizing-granulosa cells possibly via Smad5-protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26003656      PMCID: PMC4531871          DOI: 10.1007/s10815-015-0494-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  56 in total

Review 1.  Anti-Müllerian hormone and folliculogenesis.

Authors:  Jenny A Visser; Axel P N Themmen
Journal:  Mol Cell Endocrinol       Date:  2005-04-29       Impact factor: 4.102

2.  Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.

Authors:  Tomoko Miyoshi; Fumio Otsuka; Jiro Suzuki; Masaya Takeda; Kenichi Inagaki; Yoshihiro Kano; Hiroyuki Otani; Yukari Mimura; Toshio Ogura; Hirofumi Makino
Journal:  Biol Reprod       Date:  2006-01-25       Impact factor: 4.285

3.  Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

Authors:  Laura Pellatt; Laurine Hanna; Mark Brincat; Ray Galea; Henrietta Brain; Saffron Whitehead; Helen Mason
Journal:  J Clin Endocrinol Metab       Date:  2006-10-24       Impact factor: 5.958

4.  Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.

Authors:  Mikko Anttonen; Anniina Färkkilä; Hanna Tauriala; Marjut Kauppinen; David T Maclaughlin; Leila Unkila-Kallio; Ralf Bützow; Markku Heikinheimo
Journal:  Lab Invest       Date:  2011-08-01       Impact factor: 5.662

Review 5.  Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.

Authors:  Sabine Mazerbourg; Aaron J W Hsueh
Journal:  Hum Reprod Update       Date:  2006-04-07       Impact factor: 15.610

Review 6.  Anti-Müllerian hormone: a new marker for ovarian function.

Authors:  Jenny A Visser; Frank H de Jong; Joop S E Laven; Axel P N Themmen
Journal:  Reproduction       Date:  2006-01       Impact factor: 3.906

7.  Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.

Authors:  Deborah S Wachs; Mickey S Coffler; Pamela J Malcom; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2007-02-13       Impact factor: 5.958

8.  Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.

Authors:  Christine L Cook; Yong Siow; Amy G Brenner; Mary E Fallat
Journal:  Fertil Steril       Date:  2002-01       Impact factor: 7.329

9.  Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.

Authors:  S Kallio; K Aittomäki; T Piltonen; R Veijola; A Liakka; T E Vaskivuo; L Dunkel; J S Tapanainen
Journal:  Hum Reprod       Date:  2012-01-17       Impact factor: 6.918

Review 10.  TGF-beta superfamily members and ovarian follicle development.

Authors:  Phil G Knight; Claire Glister
Journal:  Reproduction       Date:  2006-08       Impact factor: 3.906

View more
  7 in total

1.  The anti-Müllerian hormone (AMH) induces forkhead box L2 (FOXL2) expression in primary culture of human granulosa cells in vitro.

Authors:  Sandro Sacchi; Federica Marinaro; Susanna Xella; Tiziana Marsella; Daniela Tagliasacchi; Antonio La Marca
Journal:  J Assist Reprod Genet       Date:  2017-06-29       Impact factor: 3.412

2.  Presence of anti-Müllerian hormone (AMH) during follicular development in the porcine ovary.

Authors:  Fernanda R C L Almeida; Natasja G J Costermans; Nicoline M Soede; Annelies Bunschoten; Jaap Keijer; Bas Kemp; Katja J Teerds
Journal:  PLoS One       Date:  2018-07-31       Impact factor: 3.240

3.  Effect of anti-müllerian hormone on the development and selection of ovarian follicle in hens.

Authors:  S J Huang; L Purevsuren; F Jin; Y P Zhang; C Y Liang; M Q Zhu; F Wang; C L Jia; Z H Wei
Journal:  Poult Sci       Date:  2020-12-26       Impact factor: 3.352

4.  Utilizing Calcium Alginate for the Assessment of Bone Morphogenetic Protein 15 Induction Effect on the Differentiation of Mesenchymal Stem Cell Derived from Human Follicular Fluid to Oocyte-Like Structure.

Authors:  Ali Reza Moghadam; Mahin Taheri Moghadam; Ghasem Saki; Roshan Nikbakht
Journal:  Adv Biomed Res       Date:  2020-12-23

Review 5.  Translational Physiology of Anti-Müllerian Hormone: Clinical Applications in Female Fertility Preservation and Cancer Treatment.

Authors:  Rachael Jean Rodgers; Jason Anthony Abbott; Kirsty A Walters; William Leigh Ledger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-07       Impact factor: 5.555

6.  The transcriptional regulator CBX2 and ovarian function: A whole genome and whole transcriptome approach.

Authors:  Leila Bouazzi; Patrick Sproll; Wassim Eid; Anna Biason-Lauber
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 7.  Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.

Authors:  Didier Dewailly; Anne-Laure Barbotin; Agathe Dumont; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-09       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.